1. Home
  2. PSTV vs SMSI Comparison

PSTV vs SMSI Comparison

Compare PSTV & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • SMSI
  • Stock Information
  • Founded
  • PSTV 1996
  • SMSI 1982
  • Country
  • PSTV United States
  • SMSI United States
  • Employees
  • PSTV N/A
  • SMSI N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • SMSI Computer Software: Prepackaged Software
  • Sector
  • PSTV Health Care
  • SMSI Technology
  • Exchange
  • PSTV Nasdaq
  • SMSI Nasdaq
  • Market Cap
  • PSTV 17.0M
  • SMSI 15.3M
  • IPO Year
  • PSTV N/A
  • SMSI 1995
  • Fundamental
  • Price
  • PSTV $0.41
  • SMSI $0.70
  • Analyst Decision
  • PSTV Strong Buy
  • SMSI Strong Buy
  • Analyst Count
  • PSTV 4
  • SMSI 1
  • Target Price
  • PSTV $7.88
  • SMSI $5.00
  • AVG Volume (30 Days)
  • PSTV 6.5M
  • SMSI 111.6K
  • Earning Date
  • PSTV 11-13-2025
  • SMSI 11-12-2025
  • Dividend Yield
  • PSTV N/A
  • SMSI N/A
  • EPS Growth
  • PSTV N/A
  • SMSI N/A
  • EPS
  • PSTV N/A
  • SMSI N/A
  • Revenue
  • PSTV $5,317,000.00
  • SMSI $18,658,000.00
  • Revenue This Year
  • PSTV $2.95
  • SMSI $0.03
  • Revenue Next Year
  • PSTV $7.89
  • SMSI $52.29
  • P/E Ratio
  • PSTV N/A
  • SMSI N/A
  • Revenue Growth
  • PSTV N/A
  • SMSI N/A
  • 52 Week Low
  • PSTV $0.16
  • SMSI $0.52
  • 52 Week High
  • PSTV $2.31
  • SMSI $1.95
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 39.93
  • SMSI 45.76
  • Support Level
  • PSTV $0.39
  • SMSI $0.71
  • Resistance Level
  • PSTV $0.52
  • SMSI $0.76
  • Average True Range (ATR)
  • PSTV 0.05
  • SMSI 0.04
  • MACD
  • PSTV -0.01
  • SMSI 0.00
  • Stochastic Oscillator
  • PSTV 10.00
  • SMSI 38.30

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.

Share on Social Networks: